• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受环孢素和更昔洛韦治疗的骨髓移植患者的眼球运动障碍

Eye movement disorders in bone marrow transplant patients on cyclosporin and ganciclovir.

作者信息

Openshaw H, Slatkin N E, Smith E

机构信息

Department of Neurology, City of Hope National Medical Center, Duarte, CA, USA.

出版信息

Bone Marrow Transplant. 1997 Mar;19(5):503-5. doi: 10.1038/sj.bmt.1700679.

DOI:10.1038/sj.bmt.1700679
PMID:9052919
Abstract

After 582 allogeneic bone marrow transplants, we have encountered four patients (0.7%) who developed transient unilateral or bilateral sixth nerve palsies. Three of the four patients also had bilateral ptosis. These signs resolved 24-48 h after cyclosporin and ganciclovir were discontinued. One patient had MRI T2 abnormalities compatible with cyclosporin neurotoxicity. We postulate that cyclosporin, possibly together with ganciclovir, can produce transient brain stem or neuromuscular dysfunction with eye movement abnormality in occasional patients.

摘要

在582例异基因骨髓移植后,我们遇到了4例患者(0.7%)出现短暂性单侧或双侧展神经麻痹。这4例患者中有3例还伴有双侧上睑下垂。停用环孢素和更昔洛韦后24 - 48小时,这些症状消失。1例患者的MRI T2异常符合环孢素神经毒性表现。我们推测,环孢素可能与更昔洛韦共同作用,在少数患者中可导致伴有眼球运动异常的短暂性脑干或神经肌肉功能障碍。

相似文献

1
Eye movement disorders in bone marrow transplant patients on cyclosporin and ganciclovir.接受环孢素和更昔洛韦治疗的骨髓移植患者的眼球运动障碍
Bone Marrow Transplant. 1997 Mar;19(5):503-5. doi: 10.1038/sj.bmt.1700679.
2
A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial.一种使用抗CD6单克隆抗体偶联磁珠的新型骨髓T细胞清除方法及其在异基因骨髓移植中预防急性移植物抗宿主病的临床应用:一项I-II期试验结果
Int J Hematol. 1999 Jan;69(1):27-35.
3
A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients.一项关于更昔洛韦和膦甲酸钠隔日给药预防高危儿科和青少年异基因干细胞移植受者巨细胞病毒(CMV)感染的II期试点研究。
Pediatr Blood Cancer. 2007 Sep;49(3):306-12. doi: 10.1002/pbc.21043.
4
Randomized comparison of oral valacyclovir and intravenous ganciclovir for prevention of cytomegalovirus disease after allogeneic bone marrow transplantation.口服伐昔洛韦与静脉注射更昔洛韦预防异基因骨髓移植后巨细胞病毒病的随机对照研究。
Clin Infect Dis. 2003 Mar 15;36(6):749-58. doi: 10.1086/367836. Epub 2003 Mar 3.
5
Eye Movement Disorders Following Allogeneic Bone Marrow Transplantation on FK506 (Tacrolimus) and Ganciclovir.接受FK506(他克莫司)和更昔洛韦治疗的异基因骨髓移植后的眼球运动障碍
J Pediatr Hematol Oncol. 2018 Jan;40(1):71-73. doi: 10.1097/MPH.0000000000000870.
6
Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.非亲缘和同胞供者慢性髓性白血病(CML)的骨髓移植:单中心经验
Bone Marrow Transplant. 1997 Dec;20(12):1057-62. doi: 10.1038/sj.bmt.1701031.
7
Ganciclovir-induced encephalopathy in a bone marrow transplant recipient.
Bone Marrow Transplant. 1999 Aug;24(4):421-3. doi: 10.1038/sj.bmt.1701933.
8
Risk-adapted pre-emptive therapy for cytomegalovirus disease in patients undergoing allogeneic bone marrow transplantation.对接受异基因骨髓移植患者的巨细胞病毒疾病采用风险适应性抢先治疗。
Bone Marrow Transplant. 2000 Apr;25(7):765-9. doi: 10.1038/sj.bmt.1702227.
9
Fulminant, CMV-associated, haemophagocytic syndrome following unrelated bone marrow transplantation.
Bone Marrow Transplant. 1998 Dec;22(12):1219-22. doi: 10.1038/sj.bmt.1701501.
10
Low incidence of acute graft-versus-host disease and recurrent leukaemia in patients undergoing allogeneic haemopoietic stem cell transplantation from sibling donors with methotrexate and dose-monitored cyclosporin A prophylaxis.接受来自同胞供体的异基因造血干细胞移植并采用甲氨蝶呤和剂量监测环孢素A预防的患者,急性移植物抗宿主病和复发性白血病的发生率较低。
Bone Marrow Transplant. 1998 Sep;22(6):541-5. doi: 10.1038/sj.bmt.1701396.

引用本文的文献

1
Pharmacovigilance study of drug-induced eye movement disorder based on FDA adverse event reports from 2004 to 2024.基于2004年至2024年美国食品药品监督管理局不良事件报告的药物性眼球运动障碍药物警戒研究
Sci Rep. 2025 Jul 1;15(1):21341. doi: 10.1038/s41598-025-05709-3.
2
Isolated diplopia associated with calcineurin inhibitor therapy in a patient with idiopathic membranous nephropathy: a case report.一名特发性膜性肾病患者接受钙调神经磷酸酶抑制剂治疗后出现孤立性复视:病例报告
BMC Nephrol. 2016 Aug 19;17(1):116. doi: 10.1186/s12882-016-0309-4.
3
Ganciclovir: an update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients.
更昔洛韦:移植受者预防巨细胞病毒感染和疾病应用的最新进展
Drugs. 2001;61(8):1153-83. doi: 10.2165/00003495-200161080-00016.